Towards an Architecture to Guarantee Both Data Privacy and Utility in the First Phases of Digital Clinical Trials
In the era of the Internet of Things (IoT), drug developers can potentially access a wealth of real-world, participant-generated data that enable better insights and streamlined clinical trial processes. Protection of confidential data is of primary interest when it comes to health data, as medical...
Main Authors: | Fabio Angeletti, Ioannis Chatzigiannakis, Andrea Vitaletti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-11-01
|
Series: | Sensors |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8220/18/12/4175 |
Similar Items
-
Enhancing Privacy in Wearable IoT through a Provenance Architecture
by: Richard K. Lomotey, et al.
Published: (2018-04-01) -
A Survey on Security, Privacy, Trust, and Architectural Challenges in IoT Systems
by: Mumin Adam, et al.
Published: (2024-01-01) -
A comprehensive study on IoT privacy and security challenges with focus on spectrum sharing in Next-Generation networks (5G/6G/beyond)
by: Lakshmi Priya Rachakonda, et al.
Published: (2024-06-01) -
Privacy-Preserving Indoor Trajectory Matching with IoT Devices
by: Bingxian Lu, et al.
Published: (2023-04-01) -
Quantum Privacy-Preserving Range Query Protocol for Encrypted Data in IoT Environments
by: Chong-Qiang Ye, et al.
Published: (2024-11-01)